勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim(China)Investment Co.Ltd.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Clinical Data Reveals 6-month "Golden Rehabilitation Period" 2020-06-04 10:00
Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar in Safety and Efficacy to Lantus(R) 2014-06-16 14:34
1